Sanofi with a $9.1B Acquisition of Blueprint & Cancer Conference Shows Successes for Diagnostics, Therapy, and Treatments

Biotech & Healthcare

Jonathan Poyer

Jun 4, 20252 min read

The Doctor is IN | May 2025

Dr. is IN Monthly Call Recordings

Jonathan Poyer

May 16, 20251 min read

Where Are the Biotech IPOs and Deals?

Biotech & Healthcare

Jonathan Poyer

May 16, 20251 min read

Commerical Aerospace Ideas and Why It is an Interesting Mid- and Long-Term Investing Opportunity

Macro Views

Jonathan Poyer

May 12, 20254 min read

Novartis to Acquire Regulus Therapeutics for $1.7B

Biotech & Healthcare

Jonathan Poyer

Apr 30, 20251 min read

Following the Trend Following Trend...

Macro Views

Jonathan Poyer

Apr 25, 20252 min read

The Doctor is IN | April 2025

Biotech & Healthcare

Jonathan Poyer

Apr 22, 20251 min read

Merck's Announcement of Successful Phase 3 Trial of Subcutaneous Keytruda Progresses Towards FDA Submission

Biotech & Healthcare

Jonathan Poyer

Mar 31, 20252 min read

AbbVie and the Influence of AI on Research

Biotech & Healthcare

Jonathan Poyer

Mar 24, 20251 min read

March Shows Some Life for Biotech M&A With Over $1.7B in Deals.

Biotech & Healthcare

Jonathan Poyer

Mar 21, 20251 min read

The Doctor is IN | March 2025

Dr. is IN Monthly Call Recordings

Jonathan Poyer

Mar 21, 20251 min read

Patient Death Associated with Sarepta Drug - Stock Plummets

Biotech & Healthcare

Jonathan Poyer

Mar 21, 20251 min read

March 2025 Riffin' on Real Estate

Riffin' on Real Estate Recordings

Jonathan Poyer

Mar 13, 20251 min read

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Biotech & Healthcare

Jonathan Poyer

Mar 6, 20252 min read

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

Biotech & Healthcare

Jonathan Poyer

Mar 6, 20251 min read

Meet the Manager: Anna Damato, PhD

Biotech & Healthcare

Jonathan Poyer

Mar 6, 20254 min read

Tariffs and Their Potential Impact on Medical Devices

Biotech & Healthcare

Jonathan Poyer

Mar 6, 20252 min read

MedTech M&A Outpacing Biotech So Far in 2025. Novartis Acquires Anthos and Cosette Acquires Mayne

Biotech & Healthcare

Jonathan Poyer

Feb 27, 20251 min read

Eli Lilly Changes to Zepbound and tirzepatide Should Broaden Access

Biotech & Healthcare

Jonathan Poyer

Feb 26, 20251 min read

FDA, HIMS, and GLP-1 Drugs; Compounding GLP-1 No Longer Broadly Allowed. Look at LLY and NOVO.

Biotech & Healthcare

Jonathan Poyer

Feb 25, 20251 min read